ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,406,691 | -40.4% | 893,668 | -23.5% | 0.12% | -29.9% |
| Q2 2023 | $9,067,312 | +15.7% | 1,168,468 | -15.0% | 0.16% | +6.5% |
| Q1 2023 | $7,834,468 | -17.3% | 1,374,468 | -14.5% | 0.15% | -14.9% |
| Q4 2022 | $9,468,576 | +41.7% | 1,607,568 | -23.0% | 0.18% | +46.0% |
| Q3 2022 | $6,680,000 | -28.6% | 2,087,568 | 0.0% | 0.12% | -26.6% |
| Q2 2022 | $9,352,000 | -16.1% | 2,087,568 | 0.0% | 0.17% | -6.6% |
| Q1 2022 | $11,148,000 | -67.6% | 2,087,568 | -10.7% | 0.18% | -59.0% |
| Q4 2021 | $34,362,000 | -29.7% | 2,337,574 | 0.0% | 0.44% | -17.7% |
| Q3 2021 | $48,879,000 | +18.2% | 2,337,574 | 0.0% | 0.54% | +28.5% |
| Q2 2021 | $41,352,000 | -27.8% | 2,337,574 | 0.0% | 0.42% | -21.9% |
| Q1 2021 | $57,271,000 | -42.1% | 2,337,574 | -20.0% | 0.54% | -38.2% |
| Q4 2020 | $98,909,000 | +35.3% | 2,921,967 | 0.0% | 0.86% | -5.9% |
| Q3 2020 | $73,078,000 | -25.9% | 2,921,967 | 0.0% | 0.92% | -33.8% |
| Q2 2020 | $98,558,000 | – | 2,921,967 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |